Free Trial
NASDAQ:ASBP

Aspire Biopharma (ASBP) Stock Price, News & Analysis

$0.28 -0.02 (-7.03%)
As of 06/27/2025 04:00 PM Eastern

About Aspire Biopharma Stock (NASDAQ:ASBP)

Key Stats

Today's Range
$0.28
$0.33
50-Day Range
N/A
52-Week Range
$0.22
$15.80
Volume
3.50 million shs
Average Volume
4.12 million shs
Market Capitalization
$14.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Aspire Biopharma Holdings, Inc., early-stage biopharmaceutical company, engages in developing and marketing of disruptive technology for delivery mechanisms for do no harm drugs in the United States. The company provides Sublingual Aspirin Product, which addresses cardiology emergencies and pain management. It develops formulation for a sublingually administered melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide, as well as formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and several other classes of drugs. The company was founded in 2021 and is based in Humacao, Puerto Rico.

Receive ASBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aspire Biopharma and its competitors with MarketBeat's FREE daily newsletter.

ASBP Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
ASBP Aspire Biopharma Holdings, Inc.
See More Headlines

ASBP Stock Analysis - Frequently Asked Questions

Aspire Biopharma's stock was trading at $0.4301 at the start of the year. Since then, ASBP shares have decreased by 33.9% and is now trading at $0.2845.
View the best growth stocks for 2025 here
.

Shares of ASBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
6/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ASBP
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$12.54 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
($2.17) per share
Price / Book
-0.13

Miscellaneous

Free Float
25,754,000
Market Cap
$14.09 million
Optionable
N/A
Beta
0.91
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:ASBP) was last updated on 6/29/2025 by MarketBeat.com Staff
From Our Partners